Key facts
- It has raised $130K.
- Notable investors include Booster Innovation Fund, Sprout Agritech.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Bontia Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Bontia Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bontia Bio
Developer of a bioactive product line designed to offer safer and more environmentally conscious flea and tick treatments for companion animals. The company offers products derived from naturally occurring fungal compounds, produced using precision fermentation, enabling pet owners to access non-toxic, sustainable treatments for their animals.
- Sector
- Business Products and Services (B2B)
- HQ
- Wellington, New Zealand
- Founded
- 2024
- Employees
- 6
- Website
- bontiabio.com/
- Ownership
- Privately Held (backing)
Bontia Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bontia Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bontia Bio in its N-PORT filings yet. We sweep new filings monthly.